References
- van Vollenhoven RF. Treatment of rheumatoid arthritis. Nat Rev Rheumatol 2009;5:531–41.
- Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis 2010;69:976–86.
- Sokka T, Haugeberg G, Asikainen J, Widding Hansen IJ, Kokko A, Rannio T, et al. Similar clinical outcomes in rheumatoid arthritis with more versus less expensive treatment strategies. Observational data from two rheumatology clinics. Clin Exp Rheumatol 2013;31:409–14.
- O’Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med 2013;369:307–18.
- Choy E, Taylor P, McAuliffe S, Roberts K, Sargeant I. Variation in the use of biologics in the management of rheumatoid arthritis across the UK. Curr Med Res Opin 2012;28:1733–41.
- Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, et al. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. Semin Arthritis Rheum 2011;41:81–9.
- Neovius M, Sundstrom A, Simard J, Wettermark B, Cars T, Feltelius N, et al. Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009. Scand J Rheumatol 2011;40:8–15.
- The National Board of Health and Welfare: Open Comparisons 2013. In: Pharmaceutical treatments- comparisons between country councils. Västerås: Edita Västra Aros. 2013;6.1.
- Mercuri M, Natarajan MK, Norman G, Gafni A. An even smaller area variation: differing practice patterns among interventional cardiologists within a single high volume tertiary cardiac centre. Health Policy 2012;104:179–85.
- Kalkan A, Roback K, Hallert E, Carlsson P. Factors influencing rheumatologists’ prescription of biological treatment in rheumatoid arthritis: an interview study. Implement Sci 2014;9:153.
- Ekerstad N, Lofmark R, Andersson D, Carlsson P. A tentative consensus-based model for priority setting: an example from elderly patients with myocardial infarction and multi-morbidity. Scand J Public Health 2011;39:345–53.
- Peterson S, Eriksson M, Tibblin G. Practice variation in Swedish primary care. Scand J Prim Health Care 1997;15:68–75.
- Jones TV, Gerrity MS, Earp J, Written case simulations: do they predict physicians behavior? J Clin Epidemiol 1990;43:805–15
- Askling J, Fored CM, Geborek P, Jacobsson LT, van Vollenhoven R, Feltelius N, et al. Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis 2006;65:707–12.
- Skinner J. Causes and consequences of regional variations in health care. In: Pauly MV, McGuire TG, Barros PP, editors. Handbook of health economics, vol. 2. The Netherlands: Elsevier BV, 2012:45–93.
- Hockley T, Costa-Font J. A common disease with uncommon treatment: European guideline variations and access to innovative therapies for rheumatoid arthritis. Policy analysis centre. London School of Economics and Political Science, 2012.